Detalhe da pesquisa
1.
Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study.
World J Urol
; 42(1): 247, 2024 Apr 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38647728
2.
The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.
World J Urol
; 42(1): 322, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38747982
3.
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.
Prostate
; 83(6): 572-579, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36705314
4.
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.
World J Urol
; 41(1): 77-84, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36509932
5.
Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach.
World J Urol
; 41(5): 1301-1308, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36920491
6.
Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?
Eur Urol
; 2024 Mar 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38494379
7.
Transperineal or Transrectal Magnetic Resonance Imaging-targeted Biopsy for Prostate Cancer Detection.
Eur Urol Focus
; 2024 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38508895
8.
The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate Biopsy.
Eur Urol Oncol
; 2024 Jan 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38272745
9.
Optimal PSA density threshold and predictive factors for the detection of clinically significant prostate cancer in patient with a PI-RADS 3 lesion on MRI.
Urol Oncol
; 41(8): 354.e11-354.e18, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37391283
10.
Impact of age on the Quadrella index assessing oncological and functional results after prostate brachytherapy: A 6-year analysis.
J Contemp Brachytherapy
; 15(2): 89-95, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37215618
11.
MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients.
Prostate Cancer Prostatic Dis
; 2023 Jul 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37452146
12.
Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.
Eur Urol Oncol
; 6(4): 406-413, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36280445
13.
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?
Eur Urol Focus
; 9(2): 298-302, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36210296
14.
A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study.
Eur Urol Focus
; 9(6): 992-999, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37147167
15.
External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Eur Urol Focus
; 9(2): 309-316, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36153227
16.
Impact of Multiparametric MRI and PSA Density on the Initial Indication or the Maintaining in Active Surveillance During Follow-Up in low-Risk Prostate Cancer.
Clin Genitourin Cancer
; 20(3): e244-e252, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35216924
17.
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications.
Urol Oncol
; 39(5): 296.e1-296.e9, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33041188
18.
External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study.
Urol Oncol
; 38(11): 847.e9-847.e16, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32466877
19.
Prospective four years of evaluation of erectile function after low-dose-rate prostate brachytherapy using baseline IIEF-5 > 16.
J Contemp Brachytherapy
; 11(3): 195-200, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-31435425
20.
Evaluation of the "Quadrella" at 3 years: New index to assess functional and oncological performance specific to prostate brachytherapy.
Brachytherapy
; 17(5): 782-787, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29936129